Group phenotypic composition in cancer.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 03 2021
Historique:
received: 02 10 2020
accepted: 09 03 2021
entrez: 30 3 2021
pubmed: 31 3 2021
medline: 4 9 2021
Statut: epublish

Résumé

Although individual cancer cells are generally considered the Darwinian units of selection in malignant populations, they frequently act as members of groups where fitness of the group cannot be reduced to the average fitness of individual group members. A growing body of studies reveals limitations of reductionist approaches to explaining biological and clinical observations. For example, induction of angiogenesis, inhibition of the immune system, and niche engineering through environmental acidification and/or remodeling of extracellular matrix cannot be achieved by single tumor cells and require collective actions of groups of cells. Success or failure of such group activities depends on the phenotypic makeup of the individual group members. Conversely, these group activities affect the fitness of individual members of the group, ultimately affecting the composition of the group. This phenomenon, where phenotypic makeup of individual group members impacts the fitness of both members and groups, has been captured in the term 'group phenotypic composition' (GPC). We provide examples where considerations of GPC could help in understanding the evolution and clinical progression of cancers and argue that use of the GPC framework can facilitate new insights into cancer biology and assist with the development of new therapeutic strategies.

Identifiants

pubmed: 33784238
doi: 10.7554/eLife.63518
pii: 63518
pmc: PMC8009660
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : R01 AG067584
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG066544
Pays : United States
Organisme : ANR
ID : ANR-18-CE35-0009
Organisme : Australian Research Council
ID : LP170101105
Organisme : MAVA Foundation
ID : 2020-2023
Organisme : Deakin University
ID : SEBE_RGS_2019

Informations de copyright

© 2021, Capp et al.

Déclaration de conflit d'intérêts

JC, JD, AN, AD, JB, PP, CA, RH, BR, BU, AM, RG, FT No competing interests declared

Références

Nat Commun. 2018 Nov 22;9(1):4931
pubmed: 30467425
Evol Appl. 2013 Jan;6(1):102-8
pubmed: 23396760
Evol Appl. 2012 Nov;5(7):757-61
pubmed: 23144661
Nature. 2015 Apr 16;520(7547):358-62
pubmed: 25855289
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
Infect Genet Evol. 2016 Apr;39:293-303
pubmed: 26861618
Trends Immunol. 2016 Mar;37(3):193-207
pubmed: 26839260
Nature. 2020 Feb;578(7796):615-620
pubmed: 31959985
Expert Rev Mol Diagn. 2020 Nov;20(11):1139-1147
pubmed: 33140979
Cell Stem Cell. 2015 Sep 3;17(3):260-71
pubmed: 26340526
Nat Biotechnol. 2011 Nov 13;29(12):1120-7
pubmed: 22081019
PLoS Biol. 2020 Nov 24;18(11):e3000926
pubmed: 33232318
Cancers (Basel). 2017 Jun 22;9(7):
pubmed: 28640191
Stem Cells. 2011 Dec;29(12):1909-14
pubmed: 21956952
Br J Cancer. 2015 May 26;112(11):1725-32
pubmed: 25965164
Bioessays. 2021 Mar;43(3):e2000222
pubmed: 33210313
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):484-499
pubmed: 28947238
Trends Ecol Evol. 2015 Oct;30(10):609-621
pubmed: 26411618
Cancer Cell. 2015 Jan 12;27(1):15-26
pubmed: 25584892
Nature. 2014 Oct 2;514(7520):54-8
pubmed: 25079331
Cancers (Basel). 2020 Aug 04;12(8):
pubmed: 32759688
J Oncol. 2019 Jun 11;2019:5189232
pubmed: 31308849
Nat Rev Cancer. 2006 Dec;6(12):924-35
pubmed: 17109012
BMC Cancer. 2019 Jul 5;19(1):666
pubmed: 31277602
Nat Commun. 2019 Nov 28;10(1):5423
pubmed: 31780652
Cell. 2017 Feb 9;168(4):613-628
pubmed: 28187284
Genes Dev. 2010 Aug 15;24(16):1731-45
pubmed: 20713517
Oncotarget. 2016 Mar 1;7(9):10051-63
pubmed: 26840267
Bioessays. 2005 Dec;27(12):1277-85
pubmed: 16299757
Biochim Biophys Acta. 2010 Jan;1805(1):105-17
pubmed: 19931353
PLoS One. 2017 Sep 18;12(9):e0185085
pubmed: 28922380
Trends Ecol Evol. 2018 Apr;33(4):269-276
pubmed: 29475741
Evol Appl. 2016 May 17;9(5):633-4
pubmed: 27398093
Cell Metab. 2019 Oct 1;30(4):720-734.e5
pubmed: 31447323
Bull Math Biol. 2018 May;80(5):954-970
pubmed: 28508297
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Nat Commun. 2018 Jul 23;9(1):2884
pubmed: 30038269
Oncogene. 2006 Sep 25;25(43):5898-905
pubmed: 16998504
Elife. 2018 Aug 14;7:
pubmed: 30103855
Cancer Res. 2018 Feb 15;78(4):845-852
pubmed: 29437766
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
J Clin Oncol. 2011 Aug 1;29(22):3085-96
pubmed: 21383288
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13474-9
pubmed: 16938860
Cancer Cell. 2019 Apr 15;35(4):618-632.e6
pubmed: 30930118
Nat Rev Cancer. 2014 May;14(5):371-80
pubmed: 24739582
Nat Rev Mol Cell Biol. 2019 Feb;20(2):69-84
pubmed: 30459476
Int J Cancer. 2017 Jun 1;140(11):2408-2413
pubmed: 28052327
Nature. 2004 Feb 26;427(6977):787
pubmed: 14985739
Cell. 2019 Jan 10;176(1-2):98-112.e14
pubmed: 30633912
Cells. 2019 Jul 13;8(7):
pubmed: 31337010
Semin Cell Dev Biol. 2017 Apr;64:79-89
pubmed: 27582427
Nat Rev Cancer. 2020 Apr;20(4):247-257
pubmed: 32094544
Science. 1987 Jan 23;235(4787):442-7
pubmed: 2432664
iScience. 2020 Jul 24;23(7):101269
pubmed: 32592998
Cancer Cell. 2020 Apr 13;37(4):471-484
pubmed: 32289271
Nature. 2019 Feb;566(7745):553-557
pubmed: 30728496
Nat Rev Cancer. 2012 Jan 12;12(2):133-43
pubmed: 22237392
Int J Oncol. 2017 Nov;51(5):1482-1496
pubmed: 29048610
J Theor Biol. 2016 Apr 7;394:77-92
pubmed: 26802481
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Front Oncol. 2018 Sep 10;8:355
pubmed: 30250824
Cell Stem Cell. 2019 Jan 3;24(1):65-78
pubmed: 30554963
Nat Rev Cancer. 2013 Oct;13(10):727-38
pubmed: 24060864
Elife. 2019 Nov 05;8:
pubmed: 31686650
Science. 2017 Jul 21;357(6348):
pubmed: 28729483
Nat Commun. 2019 Apr 23;10(1):1874
pubmed: 31015400
BMC Cancer. 2015 Feb 26;15:85
pubmed: 25881093
Trends Ecol Evol. 2020 Mar;35(3):278-291
pubmed: 31879039
Cancer Cell. 2011 Feb 15;19(2):244-56
pubmed: 21316603
Cancer Res. 2017 Sep 15;77(18):5194-5206
pubmed: 28716896
Nat Commun. 2016 May 03;7:11246
pubmed: 27138336
Evol Appl. 2019 Jun 28;12(9):1772-1780
pubmed: 31548856
Res Vet Sci. 1981 Mar;30(2):248-50
pubmed: 7255917
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
Evol Med Public Health. 2015 Mar 20;2015(1):76-87
pubmed: 25794501
Semin Cancer Biol. 2015 Jun;32:3-9
pubmed: 24530939
Science. 2016 Apr 8;352(6282):167-9
pubmed: 27124449
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):352-364
pubmed: 32798606
Nature. 2019 Sep;573(7774):439-444
pubmed: 31485072
PLoS Comput Biol. 2015 Sep 03;11(9):e1004366
pubmed: 26335202
Nat Commun. 2017 Jun 12;8:15773
pubmed: 28604738
Nature. 2016 Jun 30;534(7609):705-9
pubmed: 27338791
Cell. 2011 Aug 19;146(4):633-44
pubmed: 21854987
Sci Rep. 2020 Mar 6;10(1):4223
pubmed: 32144283
PLoS Biol. 2019 Aug 5;17(8):e3000399
pubmed: 31381560
Cancer Genet. 2012 Mar;205(3):101-12
pubmed: 22469509
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):374-9
pubmed: 26711993
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21677-82
pubmed: 21098274
Nat Rev Clin Oncol. 2019 Jul;16(7):409-424
pubmed: 30796368
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2672-7
pubmed: 26929366
Am J Vet Res. 2001 Jun;62(6):907-11
pubmed: 11400849
Ecology. 2009 Dec;90(12):3379-92
pubmed: 20120807
Genome Med. 2020 Mar 19;12(1):31
pubmed: 32192534
Br J Cancer. 2020 Mar;122(7):943-952
pubmed: 32042067
Cell. 2019 May 16;177(5):1330-1345.e18
pubmed: 30982598
Trends Cell Biol. 2019 Aug;29(8):623-634
pubmed: 31153655
Cell Stem Cell. 2017 Feb 2;20(2):233-246.e7
pubmed: 27989769
Carcinogenesis. 2005 May;26(5):916-22
pubmed: 15731168
Nature. 2014 Apr 3;508(7494):113-7
pubmed: 24695311
J Transl Med. 2011 May 27;9:79
pubmed: 21619636
Nature. 2006 Sep 7;443(7107):35-6
pubmed: 16957717
Cell Rep. 2014 Aug 7;8(3):688-95
pubmed: 25066122
Nat Rev Cancer. 2015 Aug;15(8):473-83
pubmed: 26156638
Nature. 2010 Jan 28;463(7280):545-8
pubmed: 20072127
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63
pubmed: 26831077
Bioessays. 2012 Mar;34(3):170-3
pubmed: 22231918
Nat Cell Biol. 2019 Jul;21(7):879-888
pubmed: 31263265
Vet Pathol. 2011 Mar;48(2):475-81
pubmed: 20861503
R Soc Open Sci. 2017 Oct 4;4(10):170470
pubmed: 29134064
Nat Genet. 2017 May;49(5):719-729
pubmed: 28346445
Cancers (Basel). 2020 Oct 05;12(10):
pubmed: 33027902
Nat Rev Cancer. 2012 Apr 19;12(5):323-34
pubmed: 22513401
Nature. 2017 Jun 15;546(7658):431-435
pubmed: 28607484
Semin Cell Dev Biol. 2009 Sep;20(7):869-76
pubmed: 19595782
Cancers (Basel). 2016 Jan 05;8(1):
pubmed: 26742077
Nat Med. 2018 Aug;24(8):1204-1215
pubmed: 29967352
Nature. 2013 Sep 19;501(7467):328-37
pubmed: 24048065
Sci Rep. 2020 Nov 12;10(1):19696
pubmed: 33184419

Auteurs

Jean-Pascal Capp (JP)

Toulouse Biotechnology Institute, University of Toulouse, INSA, CNRS, INRAE, Toulouse, France.

James DeGregori (J)

Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, United States.

Aurora M Nedelcu (AM)

Department of Biology, University of New Brunswick, Fredericton, New Brunswick, Canada.

Antoine M Dujon (AM)

CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.
Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, Australia.

Justine Boutry (J)

CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.

Pascal Pujol (P)

CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.

Catherine Alix-Panabières (C)

CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.
Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.

Rodrigo Hamede (R)

School of Natural Sciences, University of Tasmania, Hobart, Australia.

Benjamin Roche (B)

CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.

Beata Ujvari (B)

Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, Australia.
School of Natural Sciences, University of Tasmania, Hobart, Australia.

Andriy Marusyk (A)

Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States.

Robert Gatenby (R)

Department of Cancer Physiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, United States.

Frédéric Thomas (F)

CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH